| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 4 | -261K | 100% | $16.92 | -$4.42M |
| Net | -4 | -261K | -100% | -$4.42M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Allan M. Fox | Director | $45.8M | May 31, 2024 | ||
| Kenneth T. Mills | Director | $6.67M | -$3.07M | -31.6% | Aug 8, 2024 |
| Olivier Danos | Chief Scientific Officer | $2.78M | Aug 1, 2024 | ||
| Patrick J. Christmas | Chief Legal Officer | $2.58M | Aug 1, 2024 | ||
| Curran Simpson | Chief Executive Officer, Director | $2.55M | -$147K | -5.44% | Aug 1, 2024 |
| Steve Pakola | Chief Medical Officer | $2.48M | -$665K | -21.1% | Aug 1, 2024 |
| Vittal Vasista | Chief Financial Officer | $927K | Mar 19, 2024 | ||
| Jennifer Zachary | Director | $226K | May 31, 2024 | ||
| David C. Stump | Director | $178K | May 31, 2024 | ||
| George V. Migausky | Director | $178K | May 31, 2024 | ||
| Daniel Tasse | Director | $178K | May 31, 2024 | ||
| Alexandra Glucksmann | Director | $178K | May 31, 2024 | ||
| Jean Bennett | Director | $178K | May 31, 2024 | ||
| Argeris N. Karabelas | Director | $139K | -$530K | -79.2% | Sep 3, 2024 |
| Luke M. Beshar | Director | Jun 4, 2021 | |||
| Daniel Abdun-Nabi | Director | Jun 4, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|